BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16352927)

  • 1. [Gene therapy and molecular therapeutic for head and neck cancer].
    Tanaka H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2046-51. PubMed ID: 16352927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
    Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A replication-selective adenoviral vector for head and neck cancers.
    Tanaka H; Shirakawa T; Zhang Z; Hamada K; Gotoh A; Nibu K
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):630-4. PubMed ID: 16027288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
    Nemunaitis J; Ganly I; Khuri F; Arseneau J; Kuhn J; McCarty T; Landers S; Maples P; Romel L; Randlev B; Reid T; Kaye S; Kirn D
    Cancer Res; 2000 Nov; 60(22):6359-66. PubMed ID: 11103798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
    Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
    Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
    Edelman J; Edelman J; Nemunaitis J
    Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
    Suominen E; Toivonen R; Grenman R; Savontaus M
    J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.
    Zhu ZB; Mathis JM; Makhija SK; Lu B; Wang M; Ji S; Rivera AA; Rosenthal EL; Siegal GP; Curiel DT
    Int J Oncol; 2007 Nov; 31(5):1213-22. PubMed ID: 17912450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
    Eicher SA; Clayman GL; Liu TJ; Shillitoe EJ; Storthz KA; Roth JA; Lotan R
    Clin Cancer Res; 1996 Oct; 2(10):1659-64. PubMed ID: 9816113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From gene therapy to virotherapy for ovarian cancer.
    Stoff-Khalili MA; Dall P; Curiel DT
    Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-selective oncolytic viruses in the treatment of cancer.
    Everts B; van der Poel HG
    Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the human IAI.3B promoter element and its use in the construction of a replication-selective adenovirus for ovarian cancer therapy.
    Hamada K; Kohno S; Iwamoto M; Yokota H; Okada M; Tagawa M; Hirose S; Yamasaki K; Shirakata Y; Hashimoto K; Ito M
    Cancer Res; 2003 May; 63(10):2506-12. PubMed ID: 12750273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
    Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
    Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
    Su C; Peng L; Sham J; Wang X; Zhang Q; Chua D; Liu C; Cui Z; Xue H; Wu H; Yang Q; Zhang B; Liu X; Wu M; Qian Q
    Mol Ther; 2006 May; 13(5):918-27. PubMed ID: 16497559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
    Clayman GL; Frank DK; Bruso PA; Goepfert H
    Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.